Evogene Joins AI Drug Discovery Roadshow

• Evogene will attend the AI Drug Discovery Roadshow across the U.S. East Coast on Nov. 2-5, 2026.
• CEO Ofer Haviv will present the ChemPass AI small-molecule discovery platform to potential investors and strategic partners.
• Participation aims to expand U.S. pharmaceutical and biotechnology relationships and advance drug discovery collaborations.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Evogene Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610200800PR_NEWS_USPR_____IO76519) on October 20, 2026, and is solely responsible for the information contained therein.